Smith, Salley & Associates
- SEC CIK
- 0001482012
- Latest filing
- Jul 23, 2026
ELV holding history
Elevance Health, Inc. in every 13F filed by Smith, Salley & Associates, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
ELV overviewAll 13F holders of ELVFull Q2 2026 holdings
- Shares (Q2 2026)
- 39,707
- Value
- $15.4M
- % of portfolio
- 0.7%
- Quarters held
- 13
- Since Q2 2023
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 39,707 | $15.4M | 0.7% | +193+0.5% | Added | Holders |
| Q1 2026 | 39,514 | $11.6M | 0.6% | +1,419+3.7% | Added | Holders |
| Q4 2025 | 38,095 | $13.4M | 0.7% | −1,757−4.4% | Reduced | Holders |
| Q3 2025 | 39,852 | $12.9M | 0.7% | +8,226+26.0% | Added | Holders |
| Q2 2025 | 31,626 | $12.3M | 0.7% | +977+3.2% | Added | Holders |
| Q1 2025 | 30,649 | $13.3M | 0.9% | +944+3.2% | Added | Holders |
| Q4 2024 | 29,705 | $11.0M | 0.7% | −1,380−4.4% | Reduced | Holders |
| Q3 2024 | 31,085 | $16.2M | 1.1% | +815+2.7% | Added | Holders |
| Q2 2024 | 30,270 | $16.4M | 1.2% | +1,759+6.2% | Added | Holders |
| Q1 2024 | 28,511 | $14.8M | 1.1% | −3,476−10.9% | Reduced | Holders |
| Q4 2023 | 31,987 | $15.1M | 1.0% | +1,556+5.1% | Added | Holders |
| Q3 2023 | 30,431 | $13.2M | 1.0% | +7,080+30.3% | Added | Holders |
| Q2 2023 | 23,351 | $10.4M | 0.8% | +23,351 | New | Holders |